Clinical Trial Results:
Phase II Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkins Lymphoma Patients
Summary
|
|
EudraCT number |
2007-007091-41 |
Trial protocol |
IT |
Global completion date |
19 Jul 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
31 Jul 2019
|
First version publication date |
14 Jun 2019
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
2007-007091-41 Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.